Navidence
Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research
UndisclosedSeed
Role not disclosedGV
Grand Ventures
Activity from announced rounds
Activity in this selectionBiotech
Grand Ventures is the investment firm named in Navidence and Comp AI financing coverage, with Comp AI identifying it as co-lead.
Recorded funding activity
Comp AI automates compliance evidence, control monitoring and vendor-risk work. Navidence supplies computable disease and outcome definitions for real-world evidence research. The two financings retain their different customers and participant roles.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share